CVS Pharmacy

Rochester, NY, United States

CVS Pharmacy

Rochester, NY, United States
SEARCH FILTERS
Time filter
Source Type

News Article | May 16, 2017
Site: www.prnewswire.com

The combined 25,000 square feet of retail space will be anchored by a flex format Target store featuring a Starbucks and CVS Pharmacy. Firecakes Donuts will occupy the space closest to the transit station and Wheel & Sprocket plans to open this summer in the adjacent 1118 Westgate building. First move-ins are anticipated for Aug. 1 with construction completing in October. "We're very excited to open our doors in downtown Oak Park," said Ryan McBride, vice president of development for LMC. "This community has been a long time coming and we're thrilled to begin building our resident base. Oak Park provides a one-of-a-kind living experience with its vibrant restaurant, retail and cultural scene. We look forward to being a part of it." Situated at 1135 Westgate Street, The Emerson is a 15-minute ride from Downtown Chicago via the adjacent Metra commuter line and 'L' Station. Interstate 290 is two miles from the community, providing access to the key attractions and employment centers in both the city and suburbs. The community is adjacent to Lake Street and Marion retail corridor and within walking distance of a Whole Foods Market, Trader Joe's, Walgreens, Lake Street Theater and several other local and national dining, entertainment and shopping destinations. The Emerson consists of studio, 1- and 2-bedroom apartments with a top-of-the-line community amenities package. Included are a heated outdoor swimming pool, private cabanas with resort-quality outdoor furniture, high-end outdoor grills, landscaped outdoor deck with city views, state-of-the-art fitness center, spacious multi-sport training studio and a business center with private offices. Residents also will have access to a digital-package and dry-cleaning locker system. Apartment interiors feature quartz countertops, stainless steel appliances, European-style custom cabinetry with under-cabinet lighting in select units, glass tile backsplashes, tile shower surrounds with frameless glass doors, in-unit washers and dryers and luxury vinyl-plank flooring. Including The Emerson, LMC has more than 1,000 apartment homes in operation, planned or under construction in the Chicago area. About LMC LMC, a wholly owned subsidiary of Lennar (NYSE: LEN), is a multifamily real estate development and operating company with a diverse portfolio of institutional quality multifamily rental communities across the US. LMC has a 23,000-unit pipeline of communities ranging from operating to under development that exceeds $7 billion and consists of high-rise, mid-rise and garden apartments. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lmc-announces-start-of-preleasing-at-the-emerson-apartments-300457832.html


News Article | May 22, 2017
Site: www.prnewswire.com

Madame Dogbo is one of the female farmers benefitting from the VSLA program. In 2016, her cocoa farm was destroyed in a fire, leaving her and her four daughters in a perilous financial situation. With the help of a VSLA-funded loan, Madame Dogbo was able to plant cocoa again, and more importantly, earn the money to send her daughters to school. You can view her story, and more about the VSLA program, here. "On the VSLA meeting days, even if I have things to do like cooking, I stop everything and go there, because the VSLA has changed me—the VSLA has provided our community a great opportunity," said Madame Dogbo. The well-being of cocoa farmers is one of the most important steps of the bean to bar journey. As such, Mars, Inc. has pledged $1 million to CARE® to empower female farmers in Cote d'Ivoire. Consumers can now join those efforts. Starting July 7, for every purchase of specially marked DOVE® Chocolate PROMISES® at CVS Pharmacy locations, $1 will be donated to CARE®. "DOVE® Chocolate is thrilled to see the VSLA program with CARE has already exceeded expectations in year one," said Kerry Cavanaugh, Brand Director, DOVE® Chocolate, Mars Chocolate North America. "Through our joint efforts, we're starting to see women in these communities flourish, which impacts not only the quality of cocoa bean produced, but also education and healthcare opportunities for their family." Promoting gender equality and securing a larger voice for women within their communities has also been a major objective for DOVE® Chocolate and CARE®. Members of the 70 VSLA groups established in Cote d'Ivoire through the DOVE® partnership, have demonstrated positive group dynamics, with men and women from various backgrounds working together productively, which was uncommon before the program. "Now, women have a newfound confidence in their ability to own and manage cocoa farms," said Youssouf Ndjore, Cocoa Sustainability Director, CARE®. "Additionally, the community's perception of women is improving as men are beginning to take pride in their support of women who are running their own businesses and having dreams for the future." The DOVE® Chocolate Difference From bean to bar, Mars Chocolate North America takes great care to maintain the highest standards of quality when crafting DOVE® Chocolate. Every batch of beans is carefully and thoroughly evaluated for flavor and quality for use in DOVE® Chocolate to ensure the authentic rich taste of the cocoa is enjoyed by consumers around the world. It all starts with only the best cacao beans, which are tested by expert Mars Associate craftspeople for quality and flavor. The beans are then taken through special roasting and grinding techniques – a process rooted in European tradition - to create the signature silky smooth texture and great taste of DOVE® Chocolate. Finally, Mars adds the perfect combination of chocolate liquor and 100 percent pure cocoa butter to create a balanced taste that's not too sweet, nor too bitter. To learn more about the unique DOVE® Chocolate bean to bar process and to follow the CARE® partnership progress, please visit www.dovechocolatejourney.com. For more information about DOVE® Chocolate, visit Facebook, Twitter and Instagram. About Mars, Incorporated Mars, Incorporated is a private, family-owned business with more than a century of history, $35 billion in sales, and six diverse business segments producing some of the world's best-loved brands: PEDIGREE®, ROYAL CANIN®, IAMS®, BANFIELD® CESAR® (Petcare); M&M'S®, SNICKERS®, DOVE®, GALAXY®, MARS®, MILKY WAY®, TWIX® (Chocolate); DOUBLEMINT®, EXTRA®, ORBIT®, 5™, SKITTLES® (Wrigley); UNCLE BEN'S®, DOLMIO®, MASTERFOODS®, SEEDS OF CHANGE® (Food); ALTERRA COFFEE ROASTERS™, THE BRIGHT TEA COMPANY™, KLIX® FLAVIA® (Drinks); and COCOAVIA® (Symbioscience). Headquartered in McLean, VA, Mars operates in 421 facilities across 78 countries, where our more than 80,000 Associates —all united by the company's Five Principles of Quality, Efficiency, Responsibility, Mutuality and Freedom –strive every day to create relationships with our stakeholders that deliver growth we are proud of. For more information about Mars, Incorporated, please visit www.mars.com. Join us on Facebook, Twitter, LinkedIn and YouTube. About CARE Founded in 1945 with the creation of the CARE Package®, CARE is a leading humanitarian organization fighting global poverty. CARE places special focus on working alongside women and girls because, equipped with the proper resources, they have the power to lift whole families and entire communities out of poverty. That's why women and girls are at the heart of CARE's community-based efforts to improve education and health, create economic opportunity, respond to emergencies and confront hunger. Last year CARE worked in 94 countries and reached 80 million people. To learn more, visit www.care.org. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dove-chocolate--care-continue-work-to-empower-female-farmers-in-cote-divoire-300461025.html


The Long Live Skin campaign will start by focusing on proper sun safety during May, which is Skin Cancer Awareness Month.  The campaign will continue throughout the summer and will include in-store signage with information and tips on sun protection and skincare, additional videos with skincare advice shared via social, digital and radio, as well as special weekly ExtraCare offers on skincare, sun care and more. "We are proud to launch the Long Live Skin campaign to educate and engage consumers around skincare, and this program is a natural extension of CVS Pharmacy's ongoing efforts to help customers on their path to better health," said Judy Sansone, Senior Vice President of Front Store Business & Chief Merchant at CVS Pharmacy. "Taking good care of your skin is part of taking care of your health, so we're making it easier than ever for our shoppers to access the information and products they need, including those with greater skin health benefits." In addition, CVS Pharmacy and Johnson & Johnson have partnered with the American Cancer Society to create exclusive content for in store signage, cvs.com and the CVS Pharmacy circular.  CVS Pharmacy Beauty Consultants will share the information and tips on the importance of proper sun care and skin health with customers.  Johnson & Johnson will donate $1 for every Neutrogena or Aveeno product with SPF 15 or higher purchased from June 18-24 to the American Cancer Society to help prevent skin cancer. "We applaud CVS Pharmacy for working on a campaign to educate and empower consumers to be more proactive regarding skin health," said Dr. Richard Wender, American Cancer Society Chief Cancer Control Officer.  "We are thrilled to participate in this partnership that focuses on skin cancer prevention and early detection—to help ensure a healthy and safe summer for everyone." The Long Live Skin campaign is also supported by other initiatives focused on healthy skincare and the importance of sun protection: To learn more, https://www.cvs.com/longliveskin.  To join the Long Live Skin conversation online, share your best skincare advice with #AdviceToMyYoungerSelf on your social channels. CVS Pharmacy, the retail division of CVS Health (NYSE: CVS), is America's leading retail pharmacy with over 9,700 locations. It is the first national pharmacy to end the sale of tobacco and the first pharmacy in the nation to receive the Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry. CVS Pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS Pharmacy is available at http://www.cvshealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cvs-pharmacy-launches-long-live-skin-campaign-to-increase-awareness-around-sun-safety-and-skin-health-300457373.html


The following material contains graphic images that may be disturbing. Parents are advised that these images may not be suitable for young children. Matt and Patrice have to be very careful how they touch their beloved son, even though he touches their hearts every day. Jonah suffers from epidermolysis bullosa (EB), a rare skin disorder that causes his skin to blister or slide off at the slightest friction. The couple lost their first child late in pregnancy. Two months later they conceived again, but when their baby was born his skin was missing in places and he was screaming in agony. “It wasn’t the normal newborn baby cry that you want to hear – it was agony.” A pediatrician quickly diagnosed Jonah with epidermolysis bullosa, and told Patrice and Matt the bad news. There is no cure or treatment for the condition. “So is the only option prayer? Is that the only choice we’ve got?” Matt asked -- the doctor responded, “Yes.” Jonah needs assistance in the bathroom, and his dressings must be changed three to four times a week. “There is no part of his body that doesn’t blister,” Patrice explains. Jonah also suffers internal complications, so he now has a feeding tube. “Jonah has never known a life without pain.” However, Patrice says, “In spite of all the pain he goes through, he is just the funniest, most joyful, most charismatic little kid you’ll ever meet.” Matt adds, “It’s kind of weird for a dad to say that their son is their hero, but Jonah definitely is my hero.” Says Patrice, “He doesn’t just survive – he thrives.” Watch: Teen's Skin Is Causing Her Emotional and Physical Pain ER Physician Dr. Travis Stork wonders how Matt and Patrice cope with not being able to hug and cuddle their son freely. “We’ve just learned how to do it,” Patrice explains. “We certainly don’t deprive him of touch or affection.” It’s difficult with Jonah’s four-year-old brother, though, who wants to rough-house with his big brother. “I just intervene a lot!” says Patrice. Dermatologist Dr. Sonia Batra explains that there are several varieties of EB. In Jonah’s case, the upper layer of his skin, the epidermis, is not properly connected the layer below. So any touch can cause the two levels to shear and separate. Infection is a constant danger, and so is malnutrition because the body is constantly using resources to heal. Patrice and Matt sponsor running events to raise funds for debra of America, the national advocacy organization for EB. “Most local doctors don’t necessarily know what it is either, so you have to have somewhere to turn and that’s what they are,” Patrice explains. The Doctors have reached out to support their efforts. CVS Pharmacy and Molnycke Health Care have partnered to provide a year’s worth of bandages to debra of America! Molnycke will also provide a $1,000 CVS gift card to Matt and Patrice for Jonah’s medical supplies. But the best surprise is for Jonah himself! The little boy loves cars and racing, and has a list of favorite NASCAR drivers. Now drivers Dale Earnhardt Jr., Jimmie Johnson, Danica Patrick, Jeff Gordon, Kyle Busch, and Chase Elliott, Kevin Harvick, Joey Logano, Kurt Busch, and Kasey Kahne have made a video to thank him for being a fan, and to invite him and his family to join them at the races! “That’s totally awesome!” Jonah exclaims. And it's not just racing tickets – he’s going home with NASCAR t-shirts, caps, toys, and more. “Will all that fit in our suitcase?” he wonders. “This is amazing!”


News Article | May 18, 2017
Site: www.prweb.com

ClōSYS products which are marketed as the gentle giants of the oral care industry are known for being non-irritating while extremely helpful for mouth and gum health, which is linked to one’s overall health. Since 1991 when the ClōSYS patented formula was first introduced their professionals and customers learned quickly of the powerful ways in which ClōSYS products immediately helped eliminate bad breath as well as help reduce plaque and protect teeth and gums without the burn, foul taste, or discomfort usually found with other oral products. “As the ADA Seal of Acceptance program is a well-established and well-respected symbol of excellence in dentistry, we are delighted to have our ClōSYS rinses be the first mouth rinses awarded the ADA Seal for the management of oral malodor,” said James Ratcliff, CEO of, Rowpar Pharmaceuticals, Inc., makers of ClōSYS. "Dental professionals and patients have a lot of products to choose from and this new ADA Seal helps dental professionals and the general public better understand the ClōSYS difference. We are honored and excited to receive this recognition.” According to Andy Gritti, Executive Vice President of Rowpar, "ClōSYS rinses are great for people that are serious about their health. By taking care of the mouth we are in effect doing a lot to help the body remain healthy. The ADA seal for helping to eliminate bad breath adds great credibility for customers seeking a gentle yet effective oral care solution they can use every day.” Rowpar Pharmaceuticals manufactures and markets ClōSYS toothpaste, mouth rinse, and breath spray to dental offices, dental dealers and are sold over-the-counter through Walgreens, CVS Pharmacy, Walmart, Albertsons, CloSYS.com, Amazon.com, and others. For more information about ClōSYS visit: http://www.closys.com


"A diagnosis of lung cancer shouldn't happen by chance or when the disease is in its later stages, as it does for so many," said Harold Wimmer, National President and CEO of the American Lung Association. "We know that early detection is key – survival rates are five times higher when lung cancer is detected early. This is why awareness of lung cancer and screening options is critical in partnership with research funding to support more treatment options and methods of early detection." The American Lung Association's 3rd annual Women's Lung Health Barometer revealed that, while there have been positive shifts in women's perceptions of lung cancer, awareness remains critically low. Anyone can get lung cancer, and sadly one woman dies every eight minutes in the U.S. from the disease. Early detection and treatment of lung cancer translates to higher survival rates, however only 18 percent of lung cancer cases among women are diagnosed early, when the disease is most treatable. Survivor: Millennials vs. Gen X 2016 victor Adam Klein has joined the LUNG FORCE initiative as a LUNG FORCE Hero after losing his mother to lung cancer just one hour after returning home from the competition. Klein's mother, Susie, lost her life to the disease only nine short months after receiving a stage 4 lung cancer diagnosis. In honor of his mother's legacy, Klein most recently participated in LUNG FORCE's 2nd Annual LUNG FORCE Advocacy Day in Washington, D.C., to advocate for additional research funding. "My mother was an inspirational woman, filled with strength, love and compassion. She bravely faced the disease for nine months, but more importantly, thrived for 60 years," said Klein. "Lung cancer is the number one cancer killer of women and yet only 2 percent of women have lung cancer on their health radar so it's imperative that we make it a priority. Early detection and more effective treatment options will save lives which is why I've committed myself to raising awareness of lung cancer as well as critical funding for research in the fight against this disease." LUNG FORCE Kicks Off Social Campaign #ShowYourLUNGFORCE Without our lungs, we could not sing, dance, run or laugh – we couldn't breathe. LUNG FORCE is celebrating the power of our lungs by demonstrating the many ways we use them every day. To encourage people to take a stand against lung cancer, LUNG FORCE is launching a social campaign called #ShowYourLUNGFORCE, asking Americans to take action and mobilize their social networks to amplify awareness and raise funds to defeat lung cancer. It's easy for everyone to get involved: Donations will support the American Lung Association's investment in lung cancer research and patient support – including early detection, biomarker testing and advocacy for more federal research funding. For the fourth year in a row, LUNG FORCE National Presenting Sponsor CVS Health is rallying support with in-store fundraising. From Sunday, May 7th through Saturday, May 27th, CVS Pharmacy customers can visit any of its 7,900 stores to support LUNG FORCE by making a $1, $3 or larger donation at the register or online at Lung.org/CVS to raise funds for lung cancer awareness, research and education. The in-store fundraising campaign is part of Be The First, a 5-year $50 million initiative funded through CVS Health and the CVS Health Foundation to help deliver the nation's first tobacco-free generation. While anyone can get lung cancer, smoking is the leading risk factor for lung cancer, along with radon gas, air pollution and secondhand smoke exposure. In addition to donating to the campaign, customers can also visit Lung.org/CVS for easy ways to help their communities become tobacco-free, which is key to making a difference against lung cancer. "CVS Health is a proud sponsor of LUNG FORCE and its work to ensure that we fight the number one cancer killer," said Helena Foulkes, President, CVS Pharmacy. "As a company that is committed to helping people on a path to better health, we want to help raise funds and spread awareness of this deadly disease. Together with the American Lung Association's LUNG FORCE, we're working to create tobacco-free communities to help beat lung cancer." For more information about LUNG FORCE including local LUNG FORCE Walks taking place throughout May, visit LUNGFORCE.org. About The American Lung Association The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org. About LUNG FORCE LUNG FORCE is a national initiative led by the American Lung Association to unite women against lung cancer, the #1 cancer killer of women. LUNG FORCE has three priorities: 1) Make lung cancer a cause that people care about – and act on; 2) Educate and empower patients and healthcare providers and 3) Raise critical funds for lung cancer research. The American Lung Association's LUNG FORCE is nationally presented by CVS Health. Find out more at LUNGFORCE.org About CVS Health CVS Health is a pharmacy innovation company helping people on their path to better health. Through its nearly 9,700 retail locations, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with nearly 90 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, expanding specialty pharmacy services, and a leading stand-alone Medicare Part D prescription drug plan, the company enables people, businesses and communities to manage health in more affordable and effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health at CVSHealth.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-lung-associations-lung-force-encourages-americans-to-take-action-against-the-no-1-cancer-killer-during-national-womens-lung-health-week-may-7-13-300454084.html


— Pharmacy Retailing is drugs sold in the retail and bought on the internet, not in the hospital. This report focuses on the Pharmacy Retailing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. For more information or any query mail at sales@wiseguyreports.com Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Applications, can be divided into OTC Rx Complete Report Details @ https://www.wiseguyreports.com/reports/931952-global-pharmacy-retailing-market-forecast-to-2022 There are 15 Chapters to deeply display the global Pharmacy Retailing market. Chapter 2, to analyze the top manufacturers of Pharmacy Retailing, with sales, revenue, and price of Pharmacy Retailing, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Retailing, for each region, from 2012 to 2017; 2 Manufacturers Profiles 2.1 CVS 2.1.1 Business Overview 2.1.2 Pharmacy Retailing Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CVS Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Walgreen 2.2.1 Business Overview 2.2.2 Pharmacy Retailing Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Walgreen Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Rite Aid 2.3.1 Business Overview 2.3.2 Pharmacy Retailing Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Rite Aid Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Loblaw 2.4.1 Business Overview 2.4.2 Pharmacy Retailing Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Loblaw Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Diplomat 2.5.1 Business Overview 2.5.2 Pharmacy Retailing Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Diplomat Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Ahold? 2.6.1 Business Overview 2.6.2 Pharmacy Retailing Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Ahold? Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 AinPharmaciez 2.7.1 Business Overview 2.7.2 Pharmacy Retailing Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 AinPharmaciez Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Guoda Drugstore 2.8.1 Business Overview 2.8.2 Pharmacy Retailing Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Guoda Drugstore Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Yixintang 2.9.1 Business Overview 2.9.2 Pharmacy Retailing Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Yixintang Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Albertsons 2.10.1 Business Overview 2.10.2 Pharmacy Retailing Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Albertsons Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Pharmacy Retailing Market Competition, by Manufacturer 3.1 Global Pharmacy Retailing Sales and Market Share by Manufacturer 3.2 Global Pharmacy Retailing Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Pharmacy Retailing Manufacturer Market Share 3.3.2 Top 6 Pharmacy Retailing Manufacturer Market Share 3.4 Market Competition Trend 4 Global Pharmacy Retailing Market Analysis by Regions 4.1 Global Pharmacy Retailing Sales, Revenue and Market Share by Regions 4.1.1 Global Pharmacy Retailing Sales by Regions (2012-2017) 4.1.2 Global Pharmacy Retailing Revenue by Regions (2012-2017) 4.2 North America Pharmacy Retailing Sales and Growth (2012-2017) 4.3 Europe Pharmacy Retailing Sales and Growth (2012-2017) 4.4 Asia-Pacific Pharmacy Retailing Sales and Growth (2012-2017) 4.5 South America Pharmacy Retailing Sales and Growth (2012-2017) 4.6 Middle East and Africa Pharmacy Retailing Sales and Growth (2012-2017) 5 North America Pharmacy Retailing by Countries 5.1 North America Pharmacy Retailing Sales, Revenue and Market Share by Countries 5.1.1 North America Pharmacy Retailing Sales by Countries (2012-2017) 5.1.2 North America Pharmacy Retailing Revenue by Countries (2012-2017) 5.2 USA Pharmacy Retailing Sales and Growth (2012-2017) 5.3 Canada Pharmacy Retailing Sales and Growth (2012-2017) 5.4 Mexico Pharmacy Retailing Sales and Growth (2012-2017) For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | February 16, 2017
Site: www.businesswire.com

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global personalized gifts market to grow at a CAGR of more than 9% during the forecast period, according to their latest report. The research study by Technavio on the global personalized gifts market for 2017-2021 provides detailed industry analysis based on skill and technology (hand decoration, embroidery, engraving, printing, and carving), product (photo and non-photo personalized gifts), retail format (in-store and online), and geography (the Americas, Europe, APAC, and MEA). Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more. Technavio analysts highlight the following three key factors that are contributing to the growth of the global personalized gifts market: “The gifting culture is evolving with an increasing number of occasions when gifts are exchanged. Consumers customize gifts through personalization, configuration, or on-demand printing to add value and make their gifts unique,” says Poonam Saini, one of the lead analysts at Technavio for retail goods and services research. Seasonal decorations, such as decorative cups, plates, and napkins, account for a major portion of the total revenue generated in the market. Also, the growing home and wall décor market have also been aiding in the expansion of the growth opportunities for personalized gifts. The demand for these gifts usually experiences a surge during holidays like Christmas, Halloween, Easter, and Hanukkah. Product innovation is a requisite for this market to generate consumer interest and as an extension, its sales. A notable example is Hallmark's recent launch of Hollywood-inspired decorative ornaments based on the popular characters from popular movies, which created a lot of revenue for the market. Currently, eco-friendly gifts and novelty items are garnering significant consumer interest, particularly in children’s toys. Also, to retain consumer loyalty and increase sales, manufacturers are streamlining design and building more efficient ordering processes, enhancing customization capabilities, and brainstorming new ideas. “Retail participation across various distribution channels is an important factor that determines the growth of the global personalized gifts market. Even in the digital age, a high percentage of consumers prefer buying goods from brick-and-mortar stores, due to the personalized nature of these products,” says Poonam. Mass merchandisers, such as Walmart and Target, and pharmacy chains such as CVS Pharmacy and Rite Aid have equipped their stores with dry minilabs, which can provide on-site photo personalized gifts. Additionally, gaining consumer interest and building a brand image through the social media platform is increasing as it is cost-effective and it usually gets faster responses from a large customer base. Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cosmetics and toiletry, luggage, and pet supplies. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently. Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies. Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users. If you are interested in more information, please contact our media team at media@technavio.com.


News Article | January 12, 2017
Site: www.techtimes.com

CVS has announced that it would sell a generic version of an EpiPen competitor at a far lower price than that of the controversial EpiPen. The nation's largest drugstore chain announced on Thursday that it would sell the generic version of Impax Laboratories' Adrenaclick treatment for life-threatening allergic reactions. CVS' move is apparently a bid to offer consumers a more affordable but safe alternative to Epipen amid the skyrocketing cost of Mylan's controversial epinephrine autoinjector and following Trump lambasting drugmakers on Wednesday, Jan. 11, for the hikes in drug prices. Epipen delivers epinephrine, a synthetic adrenaline that can counter the potentially deadly effects of severe allergic reactions. People suffering from food allergies rely on Epipens for life-saving treatment, but the price of the autoinjector has swollen over the past years, making it too prohibitive for some families. In 2009, a two-pack Epipens costs only around $100, but the price has since skyrocketed to more than $600. In an effort to save, some Americans resorted to using do-it-your-own alternatives that, when used incorrectly, can have serious and even deadly consequences. Mylan, in an effort to appease the public's resentment over the pricey cost of its autoinjector, said that it would start selling a generic version of the EpiPen for $300 per two-pack, which is more than 50 percent cheaper than the price of the regular Epipen. Adrenaclick is a lesser-known epinephrine delivery product that was green-lighted by the Food and Drug Administration in 2003. Regulators do not consider it as an exact copy of the EpiPen, but it contains the same active ingredient found in Mylan's autoinjector. Adrenaclick administers the drug through a slightly different injection. CVS said that it would offer the authorized generic of Adrenaclick two-pack at $109.99 for insured and cash-paying patients without insurance, which means that it would be offered at about 80 percent of the current EpiPen price. The price of generic Adrenaclick remains cheaper even when compared with that of the generic version of EpiPen. Additional cost reductions for the generic Adrenaclick can also be availed by qualified patients who use the coupon programs offered through Impax that would provide a benefit of $100 per pack. "We are thrilled to work with CVS Health to increase access to our low-cost generic Adrenaclick epinephrine auto-injector," said Douglas Boothe, president of Generics Division at Impax Laboratories. "Families need and deserve an affordable option to treat severe allergies." CVS Pharmacy president Helena Foulkes said that Medicaid and Medicare plan members won't qualify for the $100 coupon, but CVS pharmacists will work with customers to determine the cheapest route to acquire the treatment. Foulkes said that the company responded after hearing streams of concern from customers complaining about the price increases of EpiPen. "Our focus has always been on finding solutions for patients first and foremost," Foulkes said. "The best thing that can happen to keep drug prices low is to have a lot of competition in the marketplace." © 2017 Tech Times, All rights reserved. Do not reproduce without permission.


WOONSOCKET, R.I., Feb. 22, 2017 /PRNewswire/ -- CVS Pharmacy is the first national retail pharmacy chain to announce the removal of partially hydrogenated oils (PHO), the primary source of artificial trans fats in processed foods, from all its exclusive store brands food products. The...

Loading CVS Pharmacy collaborators
Loading CVS Pharmacy collaborators